Collectively, these data suggest that EV from a proinflammatory environment may exacerbate the malignant phenotype of prostate cancer cells by manipulating the TWIST1/EMT signaling axis and that this axis may serve as a potential therapeutic target. This evidence concerns the gene TWIST1 and prostate cancer.